In this study, we demonstrated that thyroid cancer cells inhibit the function of NK cells by secreting PGE2, which inhibits the expression of NK activating receptors such as NKp44 and NKp30 and TRAIL, a death receptor ligand. This evidence concerns the gene NCR3 and thyroid gland carcinoma.